Comparative manufacture and cell-based delivery of antiretroviral nanoformulations

Autor: Georgette D. Kanmogne, Tatiana K. Bronich, Alexander V. Kabanov, Xin Ming Liu, Ram S. Veerubhotla, Andrea Martinez-Skinner, Shantanu Balkundi, Han Chen, R. Lee Mosley, Upal Roy, JoEllyn M McMillan, Ari S. Nowacek, Howard E. Gendelman
Jazyk: angličtina
Rok vydání: 2011
Předmět:
manufacturing techniques
Cyclopropanes
Medicine (General)
Pyridines
Chemistry
Pharmaceutical

Pharmaceutical Science
Indinavir
02 engineering and technology
Pharmacology
chemistry.chemical_compound
International Journal of Nanomedicine
Drug Discovery
Nanotechnology
nanoformulated antiretroviral therapy
media_common
Original Research
0303 health sciences
Nanoart
Histocytochemistry
virus diseases
General Medicine
021001 nanoscience & nanotechnology
3. Good health
Nanomedicine
Alkynes
nanotoxicology
0210 nano-technology
Oligopeptides
medicine.drug
Drug
Materials science
Efavirenz
Anti-HIV Agents
Cell Survival
media_common.quotation_subject
Atazanavir Sulfate
Biophysics
Bioengineering
Biomaterials
03 medical and health sciences
Sonication
R5-920
medicine
Humans
030304 developmental biology
Ritonavir
monocyte-derived macrophage
Macrophages
Organic Chemistry
Significant difference
Atazanavir
Benzoxazines
chemistry
Nanoparticles
human immunodeficiency virus type one
Cell based
Zdroj: International Journal of Nanomedicine
Scopus-Elsevier
International Journal of Nanomedicine, Vol 2011, Iss default, Pp 3393-3404 (2011)
ISSN: 1178-2013
1176-9114
Popis: Shantanu Balkundi1, Ari S Nowacek1, Ram S Veerubhotla1, Han Chen2, Andrea Martinez-Skinner1, Upal Roy1, R Lee Mosley1,3, Georgette Kanmogne1, Xinming Liu1,3,4, Alexander V Kabanov3,4, Tatiana Bronich3,4, JoEllyn McMillan1, Howard E Gendelman1,31Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA; 2Center for Biotechnology, University of Nebraska-Lincoln, Lincoln, NE, USA; 3Center for Drug Delivery and Nanomedicine, University of Nebraska Medical Center, Omaha, NE, USA; 4Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USAAbstract: Nanoformulations of crystalline indinavir, ritonavir, atazanavir, and efavirenz were manufactured by wet milling, homogenization or sonication with a variety of excipients. The chemical, biological, immune, virological, and toxicological properties of these formulations were compared using an established monocyte-derived macrophage scoring indicator system. Measurements of drug uptake, retention, release, and antiretroviral activity demonstrated differences amongst preparation methods. Interestingly, for drug cell targeting and antiretroviral responses the most significant difference among the particles was the drug itself. We posit that the choice of drug and formulation composition may ultimately affect clinical utility.Keywords: human immunodeficiency virus type one, nanotoxicology, monocyte-derived macrophage, nanoformulated antiretroviral therapy, manufacturing techniques
Databáze: OpenAIRE